Mr. Carrel has been President, Chief Executive Officer and director since November 2012. Since joining AtriCure, Mr. Carrel has fostered a patient-first company mission by focusing on the three core areas: innovation, clinical science and education. This strategy led AtriCure to invest in the development of a robust pipeline of novel products and groundbreaking clinical trials for the treatment of atrial fibrillation (Afib), left atrial appendage management and pain management, and continue to expand its market presence globally. These investments have driven significant growth in AtriCure's revenue, from $82 million in 2013 to $535 million in 2025, and allowed us to help more than one million patients to date. Further, market cap has increased from $115 million to approximately $2 billion as of December 31, 2025 under his leadership. During Mr. Carrel's tenure, AtriCure has acquired several companies, adding leading ablation and appendage management technologies to further AtriCure s market position worldwide. His career includes successful leadership in global organizations in healthcare and technology industries. Prior to joining AtriCure, Mr. Carrel was President and Chief Executive Officer of Vital Images, Inc., a publicly-traded medical imaging software company that was acquired by Toshiba Medical Systems Corporation. Previously, Mr. Carrel served as President and CEO of Zamba Corporation, a publicly-traded technology company, and as Chief Financial Officer of NextNet Wireless, Inc., both of which achieved successful acquisition exits. Mr. Carrel currently serves as the Board Chair of Big Brothers Big Sisters of America and has been a director since 2021. He has served on the Board of Medical Device Manufacturers Association (MDMA) since 2015 and serves on the Board of AdvaMed . He previously served as Board Chair of Axonics, Inc. from 2019 to 2024, prior to its acquisition by Boston Scientific in 2024. Mr. Carrel holds a B.S. in Accounting from Pennsylvania State University and an M.B.A. from The Wharton School at the University of Pennsylvania. Mr. Carrel has extensive leadership experience in positions advising and overseeing strategic development and management of rapid growth. His deep understanding of our business, operations and strategy and broad knowledge of the medical device industry and competitive landscape qualify him to serve on our Board of Directors.